Get started
Author

Mariona Cabo

Observed names: Cabo, Mariona, 1991-, M. Cabo, Mariona Cabo Ester
ORCID: 0000-0001-6471-2961
Observed ORCID: 0000-0001-6471-2961
OpenAlex ID: A5071512436
Targeting NK-cell checkpoints for cancer immunotherapy
2017 · Aura Muntasell, Maria C Ochoa, et al. · Current Opinion in Immunology · 185
NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival
2019 · Aura Muntasell, Federico Rojo, et al. · Clinical Cancer Research · 130
Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy
2017 · Aura Muntasell, Mariona Cabo, et al. · Frontiers in Immunology · 90
PDF
Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression
2025 · Anna Rea, Sara Santana-Hernández, et al. · Nature Immunology · 60
High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer
2019 · Aura Muntasell, Sònia Servitja, et al. · Cancer Immunology Research · 40
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
2017 · Mariona Cabo, Rienk Offringa, et al. · OncoImmunology · 37
PDF
Combination of phenotype and polygenic risk score in breast cancer risk evaluation in the Spanish population: a case –control study
2020 · J. C. Triviño, A. Ceba, et al. · BMC Cancer · 11
PDF
Data from High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer
2023 · Aura Muntasell, Sònia Servitja, et al.
Data from High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer
2023 · Aura Muntasell, Sònia Servitja, et al.
Data from CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function
2023 · Mariona Cabo, Sara Santana-Hernández, et al.
Supplementary Tables from CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function
2023 · Mariona Cabo, Sara Santana-Hernández, et al.
Data from CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function
2023 · Mariona Cabo, Sara Santana-Hernández, et al.
Supplementary Figures from CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function
2023 · Mariona Cabo, Sara Santana-Hernández, et al.
Supplementary Figures and Tables from High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer
2023 · Aura Muntasell, Sònia Servitja, et al.
PDF
Supplementary Data from NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival
2023 · Aura Muntasell, Federico Rojo, et al.
PDF
Supplementary Data from NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival
2023 · Aura Muntasell, Federico Rojo, et al.
Data from NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival
2023 · Aura Muntasell, Federico Rojo, et al.
Data from NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival
2023 · Aura Muntasell, Federico Rojo, et al.
Role of nk cells in the efficacy of anti-her2 therapeutic antibodies in breast cancer: from biomarkers to functional checkpoints enhancing adcc responses
2019 · Mariona Cabo Ester · Dialnet (Universidad de la Rioja)
Works count: 20
Citation count: 553
H-index: 7
I10-index: 7
Year
Topic
Type